SecBot SecBot
PRESS-RELEASE ·Filed Apr 29, 2026

EBS

Emergent BioSolutions
NEUTRAL
Impact 1/10
Horizonimmediate Processed6mo ago WireGlobeNewswire
Press release · Contract
Actionable Insight • Neutral

This is a non-material marketing campaign with no disclosed financial impact. No immediate trading catalyst.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$7.99
T+0 close · Apr 29, 2026 · via day close
Latest settled
−9.14%
T+60 · $7.26
Vs SPY
−13.25%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 29 $7.99entry
  2. T+1 · 7mo ago +3.00%α +1.98% · $8.23
  3. T+5 · 7mo ago +13.89%α +10.78% · $9.10
  4. T+20 · 6mo ago +14.89%α +8.85% · $9.18
  5. T+60 · 4mo ago −9.14%α −13.25% · $7.26

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Emergent BioSolutions announced a partnership with baseball player Davis Schneider to promote awareness of NARCAN Nasal Spray for opioid overdose reversal. The campaign includes an interactive Opioid Crisis Impact Map and aims to reduce stigma. No financial terms were disclosed.

Key Facts

  • Partnership with Toronto Blue Jays' Davis Schneider to promote NARCAN Nasal Spray
  • Schneider shares his personal story of losing his brother to opioid overdose on Emergent's Opioid Crisis Impact Map
  • More than 100 million doses of NARCAN Nasal Spray delivered since 2018
  • NARCAN Nasal Spray available at no cost in several Canadian provinces and territories

Financial Impact

No financial terms disclosed; campaign is primarily educational and awareness-focused.

Risk Factors

  • No discernible risk from this announcement

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3283594

Track record

23 reports on EBS

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +14.89% at T+20 after the Apr 29, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today Institutional Cluster Neutral 3/10 Entry $5.76 Now $5.81 +0.96% settles Nov 23
  2. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $5.75 Now $5.81 +1.13% settles Nov 23
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $5.79 Now $5.81 +0.35% settles Nov 23
  4. Nov 4, 202612d ago 8-K Neutral 4/10 Entry $5.85 to $5.89 Now $5.81 −0.68% ▲ +0.68% −2.61% vs SPY
  5. Nov 2, 202614d ago 8-K Bearish 6/10 Entry $6.25 to $6.05 Now $5.81 +7.04% ▲ +3.20% +2.61% vs SPY
  6. Oct 30, 202617d ago Institutional Cluster Neutral 2/10 Entry $6.81 to $6.06 Now $5.81 −14.68% ▼ −11.01% −8.31% vs SPY
  7. Oct 16, 20264w ago 8-K Neutral 3/10 Entry $6.38 to $6.23 Now $5.81 −8.93% ▼ −2.35% −2.44% vs SPY
  8. Oct 7, 20265w ago 144 Neutral 2/10 Entry $6.81 to $7.18 Now $5.81 −14.68% ▲ +5.43% +5.71% vs SPY
  9. Jun 29, 202620w ago 8-K Bullish 5/10 Entry $8.46 to $8.18 Now $5.81 −31.32% ▼ −3.31% −4.70% vs SPY
  10. Jun 4, 202623w ago Press Release Neutral 2/10 Entry $8.44 to $8.39 Now $5.81 −31.16% ▼ −0.59% +1.96% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens in 6h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 29, 2026